Fecal Microbiota Transplantation for Clostridioides Difficile Infection in Patients with Chronic Liver Disease
Background. Fecal microbiota transplantation (FMT) is a well-established therapeutic option for patients with antibiotic resistant Clostridioides difficile infection (CDI). However, the efficacy of FMT in patients with chronic liver disease remains elusive. Aims. We studied the effect of FMT on chro...
Saved in:
Main Authors: | Alireza Meighani, Maryam Alimirah, Mayur Ramesh, Reena Salgia |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | International Journal of Hepatology |
Online Access: | http://dx.doi.org/10.1155/2020/1874570 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intestinal Microbiome Changes in Fecal Microbiota Transplant (FMT) vs. FMT Enriched with Lactobacillus in the Treatment of Recurrent Clostridioides difficile Infection
by: Elvira Garza-González, et al.
Published: (2019-01-01) -
Faecal microbiota transplantation as a non-standard
therapy for the treatment of Clostridioides difficile in
an ulcerative colitis patient
by: Karolina Pendrasik, et al.
Published: (2022-12-01) -
Zinc Deficiency and the Recurrence of Clostridium difficile Infection after Fecal Microbiota Transplant: A Retrospective Cohort Study
by: Blake A. Niccum, et al.
Published: (2018-01-01) -
Clostridioides difficile infection: a changing treatment paradigm
by: Yousif Al Naser, et al.
Published: (2024-03-01) -
Gastroenterological Surgery and Management of Clostridioides difficile Infection: A Review
by: Tomonori Takano, et al.
Published: (2025-01-01)